NAPSR X CNPR EXAM PRACTICE 350 QUESTIONS
WITH DETAILED VERIFIED ANSWERS AND
RATIONALES (100% CORRECT ANSWERS
/ALREADY GRADED A+
1. What is the definition of potency in pharmacology?
A) The magnitude of maximal response that can be received from a drug
B) The amount of drug necessary to produce the desired effect
C) The speed at which a drug reaches peak concentration
D) The duration of action of a drug in the body
Correct Answer: B
Rationale: Potency refers to the amount of drug necessary to produce the desired
effect. A more potent drug requires a smaller dose to achieve the same effect as a
less potent drug. This is distinct from efficacy, which refers to the maximum effect
a drug can produce regardless of dose.
---
2. Which of the following best describes a STAT order?
A) A medication to be given at the patient's regular scheduled time
B) A drug needed immediately and given only once
C) A medication to be administered over a 24-hour period
D) A drug that requires prior authorization from insurance
1
,Correct Answer: B
Rationale: A STAT order indicates that a drug is needed immediately and is given
only once. This is used in urgent clinical situations where delay could be harmful
to the patient.
---
3. What information does the overdosage section of drug labeling provide?
A) Recommended dosing schedules for various indications
B) Signs, symptoms, and treatment of acute overdoses
C) Contraindications and warnings for drug use
D) Pharmacokinetic data and metabolism information
Correct Answer: B
Rationale: The overdosage section of drug labeling provides information on the
signs, symptoms, and treatment of acute overdoses. This helps healthcare providers
manage potential overdose situations effectively.
---
4. Which of the following is a type of drug-drug interaction?
A) Synergism only
B) Duplication, opposition (antagonism), and alteration
C) Additive effects only
D) Potentiation only
2
,Correct Answer: B
Rationale: Drug-drug interactions can be classified into three main types:
duplication (two drugs with similar effects), opposition/antagonism (one drug
opposes the effect of another), and alteration (one drug changes the effect of
another).
---
5. What is the difference between tolerance and resistance?
A) Tolerance is genetic; resistance is acquired
B) Tolerance is diminished response to a drug; resistance is a cell's ability to resist
drug effects
C) Tolerance occurs only with antibiotics; resistance occurs with all drugs
D) There is no meaningful difference between the terms
Correct Answer: B
Rationale: Tolerance refers to a diminished response to a drug over time, requiring
higher doses to achieve the same effect. Resistance refers to a cell's ability to resist
the effects of a drug on them, often seen with antibiotics and cancer therapies.
---
6. What is the primary role of a Medical Science Liaison (MSL)?
A) To directly sell pharmaceutical products to physicians
B) To serve as educators and field-based medical resources, interfacing between
company and healthcare leaders
C) To manage inventory and distribution of pharmaceutical products
D) To process insurance claims and reimbursement requests
3
, Correct Answer: B
Rationale: MSLs serve as educators and field-based medical resources. They
interface between their company and healthcare leaders, providing scientific and
clinical information without engaging in direct sales activities.
---
7. What does a "push-through" sales strategy refer to?
A) Generating patient demand for a product through direct-to-consumer
advertising
B) The company's overall efforts to demonstrate clinical efficiency, efficacy, and
cost-effectiveness of a product
C) Discounting products to encourage bulk purchasing
D) Marketing products exclusively through online channels
Correct Answer: B
Rationale: Push-through refers to the company's overall efforts to demonstrate
clinical efficiency, efficacy, and cost-effectiveness of a product to healthcare
providers and payers, encouraging them to prescribe or cover the product.
---
8. What does a "pull-through" sales strategy generate?
A) Manufacturer rebates for bulk purchases
B) Demand for the product, usually in ways consistent with health plan goals and
guidelines
C) Clinical trial data for FDA submission
4
WITH DETAILED VERIFIED ANSWERS AND
RATIONALES (100% CORRECT ANSWERS
/ALREADY GRADED A+
1. What is the definition of potency in pharmacology?
A) The magnitude of maximal response that can be received from a drug
B) The amount of drug necessary to produce the desired effect
C) The speed at which a drug reaches peak concentration
D) The duration of action of a drug in the body
Correct Answer: B
Rationale: Potency refers to the amount of drug necessary to produce the desired
effect. A more potent drug requires a smaller dose to achieve the same effect as a
less potent drug. This is distinct from efficacy, which refers to the maximum effect
a drug can produce regardless of dose.
---
2. Which of the following best describes a STAT order?
A) A medication to be given at the patient's regular scheduled time
B) A drug needed immediately and given only once
C) A medication to be administered over a 24-hour period
D) A drug that requires prior authorization from insurance
1
,Correct Answer: B
Rationale: A STAT order indicates that a drug is needed immediately and is given
only once. This is used in urgent clinical situations where delay could be harmful
to the patient.
---
3. What information does the overdosage section of drug labeling provide?
A) Recommended dosing schedules for various indications
B) Signs, symptoms, and treatment of acute overdoses
C) Contraindications and warnings for drug use
D) Pharmacokinetic data and metabolism information
Correct Answer: B
Rationale: The overdosage section of drug labeling provides information on the
signs, symptoms, and treatment of acute overdoses. This helps healthcare providers
manage potential overdose situations effectively.
---
4. Which of the following is a type of drug-drug interaction?
A) Synergism only
B) Duplication, opposition (antagonism), and alteration
C) Additive effects only
D) Potentiation only
2
,Correct Answer: B
Rationale: Drug-drug interactions can be classified into three main types:
duplication (two drugs with similar effects), opposition/antagonism (one drug
opposes the effect of another), and alteration (one drug changes the effect of
another).
---
5. What is the difference between tolerance and resistance?
A) Tolerance is genetic; resistance is acquired
B) Tolerance is diminished response to a drug; resistance is a cell's ability to resist
drug effects
C) Tolerance occurs only with antibiotics; resistance occurs with all drugs
D) There is no meaningful difference between the terms
Correct Answer: B
Rationale: Tolerance refers to a diminished response to a drug over time, requiring
higher doses to achieve the same effect. Resistance refers to a cell's ability to resist
the effects of a drug on them, often seen with antibiotics and cancer therapies.
---
6. What is the primary role of a Medical Science Liaison (MSL)?
A) To directly sell pharmaceutical products to physicians
B) To serve as educators and field-based medical resources, interfacing between
company and healthcare leaders
C) To manage inventory and distribution of pharmaceutical products
D) To process insurance claims and reimbursement requests
3
, Correct Answer: B
Rationale: MSLs serve as educators and field-based medical resources. They
interface between their company and healthcare leaders, providing scientific and
clinical information without engaging in direct sales activities.
---
7. What does a "push-through" sales strategy refer to?
A) Generating patient demand for a product through direct-to-consumer
advertising
B) The company's overall efforts to demonstrate clinical efficiency, efficacy, and
cost-effectiveness of a product
C) Discounting products to encourage bulk purchasing
D) Marketing products exclusively through online channels
Correct Answer: B
Rationale: Push-through refers to the company's overall efforts to demonstrate
clinical efficiency, efficacy, and cost-effectiveness of a product to healthcare
providers and payers, encouraging them to prescribe or cover the product.
---
8. What does a "pull-through" sales strategy generate?
A) Manufacturer rebates for bulk purchases
B) Demand for the product, usually in ways consistent with health plan goals and
guidelines
C) Clinical trial data for FDA submission
4
